Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CREXONT ® safely and effectively. See full prescribing information for CREXONT. CREXONT ® (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975
Medication labelWhy this: Advisory · dailymed-prescription
CREXONT is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication in adults.
- generic_name
- carbidopa and levodopa
- product_names
- carbidopa and levodopa
- ndc
- 64896-967, 64896-968, 64896-969, 64896-970, 64896-967-16, 64896-967-23, 64896-968-16, 64896-968-23, 64896-969-16, 64896-969-23, 64896-970-16, 64896-970-23
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en